Untreated advanced urothelial carcinoma (aUC) in the modern treatment era: Patterns of care from a decade-long national cohort. Peripheral CD8+ T cell frequencies (median) at C1D1 and C2D1 from mUC ...
Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs.
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...
T cells offer several advantages for solid tumor immunotherapy, including innate tumor recognition, human leukocyte antigen-independent killing, and a reduced risk of graft-versus-host disease. Their ...
Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...
SAN FRANCISCO--(BUSINESS WIRE)--OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of ...
Nomic Bio Inc. announced a research collaboration with the Wellcome Sanger Institute to perform large-scale proteomic profiling of human-derived peripheral blood mononuclear cell (PBMC) supernatant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results